Literature DB >> 15499602

High-mobility group protein 1(Y): metastasis-associated or metastasis-inducing?

Alice Evans1, Thomas W J Lennard, Barry R Davies.   

Abstract

Metastasis is the major cause of mortality and morbidity for patients with cancer. The high-mobility group protein 1(Y) [HMG-1(Y)] has a role in the transcription of many genes involved at different steps in the metastatic cascade and has been linked with cancer in human and animal models. This may represent a potential therapeutic target for patients. The following review summarizes and critically appraises the evidence for the role of HMG-1(Y) in metastasis. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15499602     DOI: 10.1002/jso.20136

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  22 in total

1.  HMGB1 promotes lymphangiogenesis of human lymphatic endothelial cells in vitro.

Authors:  Yuanyuan Qiu; Ying Chen; Xin Fu; Lei Zhang; Jing Tian; Quan Hao
Journal:  Med Oncol       Date:  2010-12-22       Impact factor: 3.064

Review 2.  High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma.

Authors:  S S Liau; E Whang
Journal:  Surgeon       Date:  2009-10       Impact factor: 2.392

3.  Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma.

Authors:  Liguo Lin; Kaihua Zhong; Zhongkai Sun; Guozhong Wu; Guodong Ding
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-24       Impact factor: 4.553

4.  Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice.

Authors:  Francescopaolo Di Cello; James Shin; Kirsten Harbom; Cory Brayton
Journal:  Biochem Biophys Res Commun       Date:  2013-03-29       Impact factor: 3.575

5.  Clinical value of serum HMGB1 in diagnosis and prognosis of laryngeal squamous cell carcinoma.

Authors:  Guangbin Qiu; Yunhui Li; Zheng Liu; Mengran Wang; Jingjing Ge; Xiaozhong Bai
Journal:  Med Oncol       Date:  2014-11-06       Impact factor: 3.064

6.  Polyetheylenimine-polyplexes of Spiegelmer NOX-A50 directed against intracellular high mobility group protein A1 (HMGA1) reduce tumor growth in vivo.

Authors:  Christian Maasch; Axel Vater; Klaus Buchner; Werner G Purschke; Dirk Eulberg; Stefan Vonhoff; Sven Klussmann
Journal:  J Biol Chem       Date:  2010-10-20       Impact factor: 5.157

7.  HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells.

Authors:  Sugiko Watanabe; Yasuaki Ueda; Shin-ichi Akaboshi; Yuko Hino; Yoko Sekita; Mitsuyoshi Nakao
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

8.  Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: comparison with serum SCCA, CYFRA21-1, and CEA levels.

Authors:  Xiugui Sheng; Xuelian Du; Xiaoling Zhang; Dapeng Li; Chunhua Lu; Qinshui Li; Zhifang Ma; Quqing Song; Cong Wang
Journal:  Croat Med J       Date:  2009-10       Impact factor: 1.351

9.  The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.

Authors:  Bethany M Bush; Ashton T Brock; Jiayue A Deng; Ronald A Nelson; Takita Felder Sumter
Journal:  Cell Biochem Funct       Date:  2012-09-07       Impact factor: 3.685

10.  Amino acid residues 201-205 in C-terminal acidic tail region plays a crucial role in antibacterial activity of HMGB1.

Authors:  Wei Gong; Yuan Li; Fan Chao; Gang Huang; Fengtian He
Journal:  J Biomed Sci       Date:  2009-09-14       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.